Home » Topics » BioWorld Science

BioWorld Science
RSS

New phase II trial studies arimoclomol for Gaucher's disease

June 21, 2018

Aquinnah Pharmaceuticals obtains NINDS grant to develop ALS drugs

June 21, 2018

Loss-of-function mutation in TCF12 gene linked to autosomal dominant Kallmann syndrome

June 21, 2018

GSX2 gene identified as causative of basal ganglia agenesis

June 21, 2018

Moxetumomab pasudotox pivotal trial data in relapsed/refractory hairy cell leukemia reported

June 21, 2018

Phase II dose of BAL-101553 defined in solid tumors trial

June 21, 2018

Missense mutations in GLIS1 gene are linked to malformation syndromes

June 21, 2018

Novel collaborative agreement to develop Nanotaxi-formulated DNA dengue vaccine

June 21, 2018

Cytokinetics presents data from phase II study of reldesemtiv

June 21, 2018

Luye cleared for phase I trials in China with LY-03012

June 21, 2018

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...